Supplementary Figure S13 from Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82
Authors:
- Susana S. NajeraSNSusana S. Najera
- Christopher J. RickettsChristopher J. Ricketts
- Laura S. SchmidtLSLaura S. Schmidt
- Julia I. MedinaJMJulia I. Medina
- Keita SaitoKSKeita Saito
- Lilia IlevaLILilia Ileva
- Jeffrey R. BrenderJBJeffrey R. Brender
- Amy M. JamesAJAmy M. James
- Cody J. PeerCPCody J. Peer
- Brad GoukerBGBrad Gouker
- Baktiar O. KarimBKBaktiar O. Karim
- Olga ChernovaOCOlga Chernova
Open Access
- 4 February 2025
- other
- Published by American Association for Cancer Research (AACR)